India Pharma
-
{
- All
- News
- Videos
-
India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth
A majority of companies within Nomura's coverage universe outpaced the broader pharma market in August. Zydus Lifesciences and Glenmark Pharmaceuticals posted the strongest YoY value expansion.
-
Novartis India Q1 Results: Profit At Rs 32 Crore; Revenue Up 19% To Rs 104 Crore
Novartis India Q1 net profit rose 16.7% to Rs 32.2 crore, while revenue increased 18.7% to Rs 104 crore. Ebitda jumped 29.2% year-on-year
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
India’s Pharma Market Grows At Fastest Pace In At Least Five Quarters
The year-on-year sales growth stood at 11.5 percent in July-September quarter, the highest since at least quarter ended June 2018.
-
BQuick On Feb. 19: Top 10 Stories In Under 10 Minutes
BQuick | Top news, must-read stories and columns – all served up in less than 10 minutes.
-
Biocon Says Won’t Play The Bloodbath Game In Indian Market For Now
“I don’t want to play a bloodbath game in the Indian market, for now,” says Biocon’s Kiran Mazumdar-Shaw.
-
Class Action Lawsuit Filed Against Dr Reddy's In US
The lawsuit seeks damages to compensate the class of investors for a 'purported decline' in the company's share price.
-
Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic
Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.
-
Government To Revise Drugs Law, Draft New Rules For Medical Devices
India is working on revising its drugs law to make it easier for companies to do business and to improve the safety and efficacy of locally produced drugs, the government said on Wednesday.
-
Pharma Companies To See Moderation In Growth In US Market: Icra
Indian drug industry will see moderation in growth due to slowing of business in the US market with reduction in the number of large size drugs going off patent, increased competition and generic adoption reaching saturation levels, Icra said on Thursday.
-
Pharma Exports Growth Heading For A Sharp Decline: Crisil
The pharmaceutical sector is heading for a tough time as exports growth in formulations (in US dollar terms) is expected to almost halve to 10-12 per cent annually over the next five years, a report said.
-
Give Exemption From Drug Price Control For 5 Years: Kiran Mazumdar-Shaw
Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw on Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.
-
India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth
A majority of companies within Nomura's coverage universe outpaced the broader pharma market in August. Zydus Lifesciences and Glenmark Pharmaceuticals posted the strongest YoY value expansion.
-
Novartis India Q1 Results: Profit At Rs 32 Crore; Revenue Up 19% To Rs 104 Crore
Novartis India Q1 net profit rose 16.7% to Rs 32.2 crore, while revenue increased 18.7% to Rs 104 crore. Ebitda jumped 29.2% year-on-year
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
India’s Pharma Market Grows At Fastest Pace In At Least Five Quarters
The year-on-year sales growth stood at 11.5 percent in July-September quarter, the highest since at least quarter ended June 2018.
-
BQuick On Feb. 19: Top 10 Stories In Under 10 Minutes
BQuick | Top news, must-read stories and columns – all served up in less than 10 minutes.
-
Biocon Says Won’t Play The Bloodbath Game In Indian Market For Now
“I don’t want to play a bloodbath game in the Indian market, for now,” says Biocon’s Kiran Mazumdar-Shaw.
-
Class Action Lawsuit Filed Against Dr Reddy's In US
The lawsuit seeks damages to compensate the class of investors for a 'purported decline' in the company's share price.
-
Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic
Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.
-
Government To Revise Drugs Law, Draft New Rules For Medical Devices
India is working on revising its drugs law to make it easier for companies to do business and to improve the safety and efficacy of locally produced drugs, the government said on Wednesday.
-
Pharma Companies To See Moderation In Growth In US Market: Icra
Indian drug industry will see moderation in growth due to slowing of business in the US market with reduction in the number of large size drugs going off patent, increased competition and generic adoption reaching saturation levels, Icra said on Thursday.
-
Pharma Exports Growth Heading For A Sharp Decline: Crisil
The pharmaceutical sector is heading for a tough time as exports growth in formulations (in US dollar terms) is expected to almost halve to 10-12 per cent annually over the next five years, a report said.
-
Give Exemption From Drug Price Control For 5 Years: Kiran Mazumdar-Shaw
Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw on Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.
